Related Experiment Video
Updated: May 16, 2026

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
Published on: May 23, 2025
P2X receptor stimulation amplifies complement-induced haemolysis
J L Hejl1, M Skals, J Leipziger
1Department of Biomedicine - Physiology, Aarhus University, Aarhus, Denmark.
Complement activation causes red blood cell damage via P2 receptor signaling, similar to pore-forming toxins. Blocking these P2 receptors, specifically P2X1 and P2X7, can inhibit complement-induced hemolysis, offering new therapeutic targets for hemolytic diseases.
Area of Science:
- Immunology
- Cell Biology
- Pharmacology
Background:
- Complement system activation leads to cell damage and is implicated in hemolytic disorders.
- Pore-forming toxins like alpha-hemolysin (HlyA) and alpha-toxin induce cell damage through P2 receptor activation.
- Previous research identified P2 receptor activation as a mechanism for toxin-induced hemolysis.
Purpose of the Study:
- To investigate whether complement-induced hemolysis also involves P2 receptor activation.
- To identify the specific P2 receptor subtypes involved in complement-mediated erythrocyte damage.
- To explore the potential of P2 receptor antagonists as a therapeutic strategy for hemolytic diseases.
Main Methods:
- Studied complement-induced hemolysis in murine, ovine, and human erythrocytes using human plasma and guinea pig serum.
- Utilized non-selective P2 receptor antagonists (PPADS, suramin) and specific antagonists for P2X1 and P2X7 receptors.
- Measured intracellular calcium ([Ca(2+)]i) increase and erythrocyte shrinkage following complement activation.
Main Results:
- Complement-induced hemolysis was amplified by ATP release and subsequent P2 receptor activation, mirroring HlyA and alpha-toxin effects.
- Non-selective and specific P2 receptor antagonists (P2X1, P2X7) significantly inhibited complement-induced hemolysis.
- Complement activation increased intracellular calcium and triggered erythrocyte shrinkage via KCa3.1 channels, prolonging the hemolytic process.
Conclusions:
- Complement-induced hemolysis, like that caused by certain toxins, requires purinergic signaling through P2 receptors (P2X1 and P2X7).
- Erythrocyte volume regulation mechanisms, influenced by calcium influx, modulate the duration of complement-mediated hemolysis.
- P2 receptor antagonists represent a promising therapeutic avenue for preventing or treating intravascular hemolysis and related disorders.
Related Concept Videos
Complement System
Hypersensitivity Reactions: Cytolytic Reactions
Acute Inflammation III: Local and Systemic Effects
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
GPCR Desensitization
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
